Glucotrack, Inc. Reminds Shareholders to Vote

Core Points - Glucotrack, Inc. will hold a Special Meeting of Shareholders on October 31, 2025, to vote on an Equity Purchase Agreement with Sixth Borough Capital Fund [1] - Shareholders of record as of September 23, 2025, are eligible to vote, and the company encourages prompt voting [2] - The Board of Directors recommends that shareholders vote "FOR" all proposals to ensure their shares are represented [4] Voting Information - Shareholders can vote via telephone, online, or by returning a completed proxy card [2] - Those holding shares in multiple accounts will receive separate voting materials and must vote for each account [3] - Additional details regarding the proposals are available in the definitive proxy statement filed with the SEC on October 3, 2025 [5] Company Overview - Glucotrack, Inc. focuses on developing novel technologies for diabetes management, including a long-term implantable continuous blood glucose monitoring system [7] - The Glucotrack CBGM system is designed to measure blood glucose levels continuously with a sensor longevity of 3 years and minimal calibration [8]